01
A cellular foundation
Mesenchymal MSC
A physician-assessed MSC program considered within a broader longevity plan. The exact approach is selected only after reviewing your health history, goals and suitability.


Stem Cell & Regenerative Medicine · Bangkok
Explore LINNA's physician-assessed Stem Cell programs in one clear pathway—beginning with your medical context, not a predetermined treatment.
Suitability and outcomes vary. Regenerative programs do not replace standard medical care and are not guaranteed to treat or cure disease.
Start with clarity
Regenerative medicine studies how cells, tissues and biological signals may support repair and function. Mesenchymal stem cells are one area of active research, with different approaches explored for different tissues and health questions.
That scientific potential does not make every program appropriate—or every claim proven. At LINNA, your physician considers the quality of available evidence alongside your diagnosis, medical history, current treatment and personal goals.
The result may be a regenerative plan, a request for further investigation, coordination with your specialist, or advice not to proceed. Medical clarity comes before treatment.
Program pathways
These categories help organise the consultation. They are not standard packages or promises of a clinical outcome.
01
A cellular foundation
A physician-assessed MSC program considered within a broader longevity plan. The exact approach is selected only after reviewing your health history, goals and suitability.

02
Joint and cartilage focus
A focused discussion for patients seeking a medical opinion on regenerative options related to joint function, mobility and cartilage health.

03
Vascular and circulation focus
An assessment-led pathway for questions involving vascular and circulatory health. It does not replace cardiovascular diagnosis or standard treatment.

04
Brain and nervous system focus
A specialist conversation about emerging regenerative approaches related to the nervous system. Evidence, limitations and alternatives are reviewed carefully.

A passage refers to each time stem cells grown in a laboratory are moved into a fresh culture vessel to allow continued growth. The passage number records how many times this process has taken place.
Repeated cultivation may alter the cells’ growth capacity and biological properties. Lower-passage cells, such as P3–P5, have undergone fewer transfers, but passage number alone does not determine cell quality or predict treatment outcomes.
The appropriate passage is selected through laboratory evaluation and medical review, taking into account the cell source, quality testing and intended care plan.

Assessing cell quality involves more than checking a single measurement. It requires evaluating where the cells come from, how they are prepared and whether the proposed programme is appropriate for the individual.

Your treatment journey
International planning can begin before you arrive in Bangkok. The clinical decision still follows a complete physician review.
Tell our International Care Team about your goals, current diagnoses, medication and previous treatment. Relevant medical records can be reviewed before travel.
Your physician discusses your history, examines the questions you want answered and may recommend laboratory tests or additional specialist input.
If a regenerative program is medically reasonable, the team explains the proposed pathway, preparation, uncertainties, practical timing and cost before you decide.
Approved treatment is delivered under clinical supervision. Aftercare and follow-up are tailored to the procedure and your wider care plan.

Quality & safety
Quality is more than a reassuring label. It includes the clinical decision, the proposed cell product, handling and documentation, a suitable setting, and honest communication about what is known and uncertain.
Ask what product is proposed, where it comes from and how it has been processed, tested, transported and stored. LINNA explains the documentation relevant to your plan.
Assessment may identify reasons to delay, modify or not proceed. A consultation is an evaluation, not an automatic approval for treatment.
Medical oversight continues from initial review through treatment planning and follow-up. Existing specialist care remains important.
Stem cell science continues to develop. LINNA does not promise a cure, reversal of ageing or a guaranteed response.
International patients
Our International Care Team helps organise the information your physician needs, your Bangkok appointment and the practical timing around assessment, treatment and follow-up.

Frequently asked
Mesenchymal stem cells, often shortened to MSCs, are multipotent cells studied for their ability to develop into certain specialised cell types and to participate in cellular signalling. How that research relates to an individual patient requires careful medical interpretation.
That cannot be determined from a website or a single symptom. LINNA begins with your medical history, goals, current care and relevant investigations before discussing whether any program is appropriate.
No. Response and suitability vary, and evidence differs by condition and protocol. Your physician will discuss the uncertainties, alternatives and practical expectations relevant to you.
No. Regenerative medicine should not be used to stop or replace prescribed care without guidance from the clinician managing your condition. LINNA may request coordination with your treating specialist.
A concise medical summary, current medication list, recent laboratory or imaging reports, previous treatment records and the questions you want the physician to address are helpful starting points.
Request a medical assessment online or contact the International Care Team by WhatsApp or email. The team will advise which records to share and whether an in-person visit should be arranged.
Our customers
Thank you for your trust and for choosing us to be part of your health journey.









Your next step
Share your health context and questions with LINNA. Our team will help you prepare for a physician review and a clear discussion of whether regenerative medicine belongs in your care plan.